AZD-3289

Overview

AZD-3289 is a potent BACE1 inhibitor with potential Alzheimer's disease inhibitory activity. The application of AZD-3289 is intended to slow the pathological progression of Alzheimer's disease by inhibiting the production of β-amyloid protein. The development of AZD-3289 responds to the need to reduce neurodegenerative changes associated with Alzheimer's disease. As a BACE1 inhibitor , AZD-3289 can effectively reduce the accumulation of β-amyloid peptide in the brain, which may improve cognitive function.

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Endogenous Metabolite

Product Information

• Catalog No.: HY-116580
• CAS No.: 1227163-49-6
• Molecular Formula: C24H14F5N5
• Molecular Weight: 467.39
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source